ask="14.98"
ask_size="200"
average_daily_volume="2036960"
bid="9.12"
bid_size="200"
book_value="-0.09"
change="+0.67"
change_from_200_day_moving_average="1.76"
change_from_50_day_moving_average="1.22"
change_from_52_week_high="-1.61"
change_From_52_week_low="5.66"
change_in_percent="+5.54%"
close="12.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94833000"
high="12.83"
high_52_weeks="14.38"
last_trade_date="2/9/2017"
last_trade_price="12.77"
last_trade_size="54645"
last_trade_time="4:00pm"
low="12.08"
low_52_weeks="7.11"
market_capitalization="1.64B"
moving_average_200_day="11.01"
moving_average_50_day="11.55"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.08"
pe_ratio="N/A"
peg_ratio="-0.25"
percent_change_from_200_day_moving_average="+16.04%"
percent_change_from_50_day_moving_average="+10.58%"
percent_change_from_52_week_high="-11.20%"
percent_change_from_52_week_low="+79.61%"
previous_close="12.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.70"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="9.08"
stock_exchange="NMS"
symbol="HALO"
volume="1759130"
weeks_range_52="7.11 - 14.38"
